We are live on ! Find out more
CYTK icon

Cytokinetics
CYTK

134 hedge funds and large institutions have $315M invested in Cytokinetics in 2017 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 43 increasing their positions, 46 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 21

2% more funds holding

Funds holding: 132 → 134 (+2)

7% less repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 46

2.32% less ownership

Funds ownership: 73.92% → 71.59% (-2.3%)

38% less call options, than puts

Call options by funds: $1.24M | Put options by funds: $1.99M

45% less capital invested

Capital invested by funds: $575M → $315M (-$261M)

Holders
134
Holders Change
+2
Holders Change %
+1.52%
% of All Funds
3.04%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
24
Increased
43
Reduced
46
Closed
21
Calls
$1.24M
Puts
$1.99M
Net Calls
-$754K
Net Calls Change
-$3.51M

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$50.9M
2
WA
Wasatch Advisors
Utah
+$11.1M
3
State Street
State Street
Massachusetts
+$10M
4
BlackRock
BlackRock
New York
+$4.47M
5
TCM
Tekla Capital Management
Massachusetts
+$3.98M

Top Sellers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$40.3M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$24.7M
3
Citadel Advisors
Citadel Advisors
Florida
-$9.4M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$9.33M
5
Invesco
Invesco
Georgia
-$7.56M
Name Holding Trade Value Shares
Change 		Change in
Stake
FDCDDQ
126
Federation des caisses Desjardins du Quebec
Quebec, Canada
$3.26K -$54.2K -4,773 -92%
AG
127
Advisor Group
Arizona
$2K -$4.54K -400 -57%
KF
128
Krilogy Financial
Missouri
$2K -$2.27K -200 -50%
LJHT
129
Laurie J. Hall Trustee
$2K -$1.36K -120 -31%
GEA
130
Glen Eagle Advisors
New Jersey
$1.02K – – –
HR
131
Howe & Rusling
New York
$1K – – –
AWM
132
Avior Wealth Management
Nebraska
$1K +$341 +30 +21%
Janus Henderson Group
133
Janus Henderson Group
United Kingdom
– -$40.3M -2,778,605 Closed
Russell Investments Group
134
Russell Investments Group
United Kingdom
– -$2.75M -190,026 Closed
GC
135
Guggenheim Capital
Illinois
– -$1.79M -123,456 Closed
NI
136
Numeric Investors
Massachusetts
– -$1.67M -114,894 Closed
MCM
137
Matarin Capital Management
New York
– -$1.01M -69,882 Closed
NFA
138
Nationwide Fund Advisors
Ohio
– -$963K -66,447 Closed
SAM
139
Shell Asset Management
Netherlands
– -$607K -41,875 Closed
GIP
140
Granite Investment Partners
California
– -$576K -39,732 Closed
DCM
141
Dupont Capital Management
Delaware
– -$333K -22,940 Closed
CGH
142
Crossmark Global Holdings
Texas
– -$311K -21,460 Closed
GW
143
GW & Wade
Massachusetts
– -$290K -20,000 Closed
MC
144
Miles Capital
Iowa
– -$200K -13,781 Closed
GCP
145
GSA Capital Partners
United Kingdom
– -$187K -12,900 Closed
SG Americas Securities
146
SG Americas Securities
New York
– -$136K -9,360 Closed
PI
147
PineBridge Investments
New York
– -$91K -6,261 Closed
PA
148
Parallel Advisors
California
– -$14K -1,200 Closed
SWA
149
Sutton Wealth Advisors
Florida
– -$9.05K -624 Closed
TWA
150
TCI Wealth Advisors
Arizona
– -$1K -80 Closed
3 4 5
6
7

CYTK Hedge Fund Activity: Q4 2017 in Review

134 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q4 2017, worth a combined $315M — down 45% from $575M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new CYTK positions and 21 closed out — a net gain of 3 holders — while 43 added to existing stakes and 46 trimmed.

The largest buyer was BVF Inc, adding an estimated $50.9M. The largest seller was Janus Henderson Group, exiting entirely with an estimated $40.3M sold.

  • 134 institutional investors held Cytokinetics (CYTK) as of Q4 2017, up from 132 in Q3 2017.
  • Funds reported $315M of Cytokinetics stock for Q4 2017, down 45% quarter-over-quarter.
  • 24 funds opened new Cytokinetics positions in Q4 2017 and 21 closed out, a net change of +3 holders.
  • The largest Cytokinetics buyer in Q4 2017 was BVF Inc, an estimated $50.9M added.
  • The largest Cytokinetics seller in Q4 2017 was Janus Henderson Group, an estimated $40.3M sold.

Based on aggregated 13F filings for Q4 2017.